Fabrication and evaluation of valsartan–polymer– surfactant composite nanoparticles by using the supercritical antisolvent process

References

• MarkhamAGoaKLValsartan. A review of its pharmacology and therapeutic use in essential hypertensionDrugs19975422993119257084
   PubMed Web of Science ®Google Scholar
• YanYDSungJHKimKKNovel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changesInt J Pharm20124221–220221022085435
   PubMedGoogle Scholar
• FleschGMüllerPLloydPAbsolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in manEur J Clin Pharmacol19975221151209174680
   PubMed Web of Science ®Google Scholar
• MbahCJPhysicochemical properties of valsartan and the effect of ethyl alcohol, propylene glycol and pH on its solubilityPharmazie2005601184985016320948
   PubMed Web of Science ®Google Scholar
• ParkYJLeeHKImYBLeeWHanHKImproved pH-independent dissolution and oral absorption of valsartan via the preparation of solid dispersionArch Pharm Res20103381235124020803127
   PubMed Web of Science ®Google Scholar
• PoudelBKMarasiniNTranTHChoiHGYongCSKimJOFormulation, characterization and optimization of valsartan self-microemulsifying drug delivery system using statistical design of experimentChem Pharm Bull (Tokyo)201260111409141823124565
   PubMed Web of Science ®Google Scholar
• BegSSwainSSinghHPPatraChNRaoMEDevelopment, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriersAAPS Pharm Sci Tech201213414161427
   PubMed Web of Science ®Google Scholar
• BaekIHKimJSHaESOral absorption of a valsartan-loaded spray-dried emulsion based on hydroxypropylmethyl celluloseInt J Biol Macromol20146922222824879921
   PubMed Web of Science ®Google Scholar
• MaQSunHCheEUniform nano-sized valsartan for dissolution and bioavailability enhancement: influence of particle size and crystalline stateInt J Pharm20134411–2758123266761
   PubMedGoogle Scholar
• KimMSKimJSChoWSupersaturatable formulations for the enhanced oral absorption of sirolimusInt J Pharm20134451–210811623396259
   PubMedGoogle Scholar
• BaekIHKimMSImproved supersaturation and oral absorption of dutasteride by amorphous solid dispersionsChem Pharm Bull (Tokyo)2012601468147323124571
   PubMed Web of Science ®Google Scholar
• ChoiJHLeeKHongSEffect of biocompatible polymers on the physicochemical and dissolution properties of fenofibrate in nanoparticle systemJournal of Pharmaceutical Investigation201343507512
   Google Scholar
• KimMSInfluence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructuresInt J Nanomedicine201382029203923737668
   PubMed Web of Science ®Google Scholar
• NalawadeSPPicchioniFJanssenLSupercritical carbon dioxide as a green solvent for processing polymer melts: Processing aspects and applicationsProg Polym Sci2006311943
   Web of Science ®Google Scholar
• KimMSLeeSParkJSWooJSHwangSJMicronization of cilostazol using supercritical antisolvent (SAS) process: effect of process parametersPowder Technol20071776470
   Web of Science ®Google Scholar
• KarnPRChoWParkHJParkJSHwangSJCharacterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham methodInt J Nanomedicine2013836537723378759
   PubMed Web of Science ®Google Scholar
• CoceroMJMartínÁMatteaFVaronaSEncapsulation and co-precipitation processes with supercritical fluids: fundamentals and applicationsJ Supercrit Fluids200947546555
   Web of Science ®Google Scholar
• KimMSKimJSParkHJChoWKChaKHHwangSJEnhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent processInt J Nanomedicine201162997300922162657
   PubMed Web of Science ®Google Scholar
• KimMSKimJSChoWParkHJHwangSJOral absorption of atorvastatin solid dispersion based on cellulose or pyrrolidone derivative polymersInt J Biol Macromol20135913814223567288
   PubMed Web of Science ®Google Scholar
• HaESChooGHBaekIHDissolution and bioavailability of lercanidipine-hydroxypropylmethyl cellulose nanoparticles with surfactantInt J Biol Macromol201472C21822225159878
   PubMedGoogle Scholar
• ChaKHChoKJKimMSEnhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxideInt J Nanomedicine201275565557523118538
   PubMed Web of Science ®Google Scholar
• KimMSJinSJKimJSPreparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) processEur J Pharm Biopharm200869245446518359211
   PubMed Web of Science ®Google Scholar
• WenHMorrisKRParkKHydrogen bonding interactions between adsorbed polymer molecules and crystal surface of acetaminophenJ Colloid Interface Sci200529032533516153902
   PubMed Web of Science ®Google Scholar
• KojimaTHigashiKSuzukiTTomonoKMoribeKYamamotoKStabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPOPharm Res2012292777279122219167
   PubMed Web of Science ®Google Scholar
• EedaraBBKankaneMJukantiRNagabandiVKBandariSEnhanced solubility and permeability of exemestane solid dispersion powders for improved oral deliveryJournal of Pharmaceutical Investigation201343229242
   Google Scholar
• AdeliEMortazaviSADesign, formulation and evaluation of Azithromycin binary solid dispersion using Kolliphor series for the solubility and in vitro dissolution rate enhancementJournal of Pharmaceutical Investigation201444119131
   Google Scholar
• KhanKARhodesCTEffect of compaction pressure on the dissolution efficiency of some direct compression systemsPharm Acta Helv197247105946074642457
   PubMedGoogle Scholar
• PalanisamyMKhanamJEffect of physiochemical variables on phase solubility and dissolution behavior of indomethacin solid dispersion systemJournal of Pharmaceutical Investigation201444147162
   Google Scholar